Validation of Melanoma Immune Profile (MIP), a Prognostic Immune Gene Prediction Score for Stage II-III Melanoma

PURPOSE: Biomarkers are needed to stratify patients with stage II-III melanoma for clinical trials of adjuvant therapy because, while immunotherapy is protective, it also confers the risk of severe toxicity. We previously defined and validated a 53-immune gene melanoma immune profile (MIP) predictiv...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Clin Cancer Res
Main Authors: Gartrell, Robyn D., Marks, Douglas K., Rizk, Emanuelle M., Bogardus, Margaret H., Gérard, Camille L., Barker, Luke W., Fu, Yichun, Esancy, Camden L., Li, Gen, Ji, Jiayi, Rui, Shumin, Ernstoff, Marc S., Taback, Bret, Pabla, Sarabjot, Chang, Rui, Lee, Sandra J., Krolewski, John J., Morrison, Carl, Saenger, Yvonne M.
Format: Artigo
Sprog:Inglês
Udgivet: 2019
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6594682/
https://ncbi.nlm.nih.gov/pubmed/30647081
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-18-2847
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker